Navigation Links
Applikon and Finesse Solutions Introduce TruConnect(TM)

SANTA CLARA, Calif., Feb. 29 /PRNewswire/ -- Finesse Solutions, LLC and Applikon Biotechnology Inc, announced the general release of the TruConnect(TM) gateway, a migration device designed to provide an interface between Applikon ADI 1010 and ADI 1030 Controllers, and the Finesse TruLogic(TM) Controller, enabled by Finesse's TruBio(TM) software (based on DeltaV(TM) control.)

TruConnect(TM) gateways harmonize an installed base of different ADI bioreactor controllers onto the same DeltaV(TM) control system platform. This harmonization can be made in phases, in order to lower budgetary costs and operating risk by leveraging three versions of TruBio(TM) software: TruBio(TM) Monitor for data collection only; TruBio(TM) SCADA for supervisory control; and TruBio(TM) OS for truly "active" control.

With TruBio(TM) software, end users can reduce their operators' learning curve with a uniform, intuitive user interface, increase flexibility with an open, fully configurable system, and improve efficiency with save/load replication of set-points and control loop parameters.

Applikon's President, John Chory, stated "The collaboration with Finesse has enabled us to ensure our customers that their substantial investment in our control products over the years can be easily migrated to an Applikon supported DeltaV solution whenever they require."

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at

About Applikon

Applikon is a privately owned Netherlands based company of which the Biotechnology division develops, manufactures and supplies bioreactor and control systems for research, pilot scale, and production. Founded in 1973, Applikon has grown into a global enterprise capable of supplying a broad and diverse line of bioreactor and control systems. Applikon autoclavable bioreactor systems are the worldwide industry standard. Applikon controllers comply with the highest standards applied in the pharmaceutical industry. AppliSens, owned by Applikon, presents sensors and perfusion systems for application in bio-processes under GMP conditions.

Applikon is headquartered in Schiedam, the Netherlands, with major operations in Foster City (USA), Eckington (UK), and in more than 12 countries. For more information refer to

SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. John OConnell Joins Finesse Solutions as Vice-President of Sales and Business Development
2. Toxic Neglect: Mutual Funds Opposing Shareholder Resolutions on Chemicals in Products Ignore Financial Risks to Shareholders
3. Plexus Systems, Inc. Names Stosz to Solutions Engineer
4. ( Updates Investment Community Through All-New Interview With digiMedical Solutions
5. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
6. Video: YMCAs Commit to Helping Americans Keep Their New Years Resolutions in Support of Health and Well-Being
7. SXC Health Solutions Corp. to acquire National Medical Health Card Systems, Inc.
8. Elsevier enhances clinical decision making with suite of Clinical Decision Support solutions
9. Harris Corporation Demonstrates Digital Signage(TM) Solutions for Dynamic, Rapid Communications within Healthcare Enterprises
10. Colubris Demonstrates Wide-Ranging Mobility Solutions for Healthcare
11. Antares Management Solutions Earns Top ISO Re-Certification
Post Your Comments:
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... the recent 2015 American Dental Association meeting in Washington D.C. revolved around the fact ... a patient’s overall health. The talk stressed the link between periodontal disease (more commonly ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... care in America. As people age, more care is needed, especially with Alzheimer’s, ... and medical professionals are being overworked. The forgotten part of this equation: 80 ...
(Date:11/27/2015)... ... November 27, 2015 , ... "When I was traveling, I ... Hillside, N.J. "Many people catch diseases simply from sitting on such dirty toilet ... protected from germs." , He developed the patent-pending QUDRATECS to eliminate the need ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... ... use in Final Cut Pro X. With ProSidebar: Fasion, video editors can easily ... use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop zones, ...
(Date:11/27/2015)... ... 27, 2015 , ... Intellitec Solutions announced today that they ... Recognized as Microsoft’s official group for end users of Dynamics SL ERP software, ... industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ongoing commitment to ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Nov. 27, 2015  Lannett Company, ... it has completed the acquisition of Kremers Urban ... subsidiary of global biopharmaceuticals company UCB S.A. (Euronext: ... Lannett has acquired KU from UCB for ... certain adjustments, including a customary working capital adjustment, ...
(Date:11/27/2015)... 26, 2015 ... the "2016 Global Tumor Marker Testing ... and Sales Segment Forecasts, Innovative Technologies, Instrumentation ... to their offering. --> ... "2016 Global Tumor Marker Testing Market: ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
Breaking Medicine Technology: